批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2016/02/05 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/02/05 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/11/14 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
UNKNOWN
|
|
|
2014/09/24 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/03/28 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMLODIPINE BESYLATE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;160MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021990 |
002 |
NDA |
EXFORGE |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
Yes |
No |
AB |
2007/06/20
|
NOVARTIS |
090011 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2013/03/28
|
STRIDES PHARMA |
090245 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/03/30
|
LUPIN |
090483 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/03/30
|
MYLAN |
202829 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/03/30
|
NOVEL LABS INC |
202713 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/04/03
|
ALEMBIC |
206512 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2016/04/22
|
AUROBINDO PHARMA |
205137 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2016/09/16
|
HETERO LABS |
207292 |
001 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;160MG |
Prescription |
No |
No |
AB |
2024/10/11
|
MACLEODS PHARMS LTD |
活性成分:AMLODIPINE BESYLATE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;160MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021990 |
003 |
NDA |
EXFORGE |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
Yes |
Yes |
AB |
2007/06/20
|
NOVARTIS |
090011 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2013/03/28
|
STRIDES PHARMA |
090245 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/03/30
|
LUPIN |
090483 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/03/30
|
MYLAN |
202829 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/03/30
|
NOVEL LABS INC |
202713 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2015/04/03
|
ALEMBIC |
206512 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2016/04/22
|
AUROBINDO PHARMA |
205137 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2016/09/16
|
HETERO LABS |
207292 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;160MG |
Prescription |
No |
No |
AB |
2024/10/11
|
MACLEODS PHARMS LTD |
活性成分:AMLODIPINE BESYLATE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;320MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021990 |
004 |
NDA |
EXFORGE |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
Yes |
No |
AB |
2007/06/20
|
NOVARTIS |
090011 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2013/03/28
|
STRIDES PHARMA |
090245 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/03/30
|
LUPIN |
090483 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/03/30
|
MYLAN |
202829 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/03/30
|
NOVEL LABS INC |
202713 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/04/03
|
ALEMBIC |
206512 |
002 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2016/04/22
|
AUROBINDO PHARMA |
205137 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2016/09/16
|
HETERO LABS |
207292 |
003 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 5MG BASE;320MG |
Prescription |
No |
No |
AB |
2024/10/11
|
MACLEODS PHARMS LTD |
活性成分:AMLODIPINE BESYLATE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;320MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021990 |
005 |
NDA |
EXFORGE |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
Yes |
Yes |
AB |
2007/06/20
|
NOVARTIS |
090011 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2013/03/28
|
STRIDES PHARMA |
090245 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/03/30
|
LUPIN |
090483 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/03/30
|
MYLAN |
202829 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/03/30
|
NOVEL LABS INC |
202713 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2015/04/03
|
ALEMBIC |
206512 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2016/04/22
|
AUROBINDO PHARMA |
205137 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2016/09/16
|
HETERO LABS |
207292 |
004 |
ANDA |
AMLODIPINE BESYLATE AND VALSARTAN |
AMLODIPINE BESYLATE; VALSARTAN |
TABLET;ORAL |
EQ 10MG BASE;320MG |
Prescription |
No |
No |
AB |
2024/10/11
|
MACLEODS PHARMS LTD |